NASDAQ:STXS

Stereotaxis Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy STXS

*Your capital is at risk

$1.84

-0.130 (-6.60%)

At Close: Jun 03, 2026

Stereotaxis Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 3.37M and sold 0 STXS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	3.37M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 01, 2024 Buy	Common Stock A-Award	Menawat Arun Swarup Director	Director	53 475 Value: $94.7K
Jul 01, 2024 Buy	Common Stock A-Award	Curet Myriam Director	Director	53 475 Value: $94.7K
Jul 01, 2024 Buy	Common Stock A-Award	Benfer David Director	Director	53 475 Value: $94.7K
Jul 01, 2024 Buy	Common Stock A-Award	Fischel Nathan	Director	53 475 Value: $94.7K
Jul 01, 2024 Buy	Common Stock A-Award	Fischel Nathan	Director	53 475 Value: $94.7K
Jul 01, 2024 Buy	Common Stock A-Award	Benfer David Director	Director	53 475 Value: $94.7K
Jul 01, 2024 Buy	Common Stock A-Award	Curet Myriam Director	Director	53 475 Value: $94.7K
Jul 01, 2024 Buy	Common Stock A-Award	Menawat Arun Swarup Director	Director	53 475 Value: $94.7K
Jul 01, 2024 Buy	Common Stock A-Award	Levin Ross B Director	Director	53 475 Value: $94.7K
Jun 14, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	7 000 Value: $13.0K
Jun 14, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	7 000 Value: $13.0K
May 31, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	1 000 Value: $2K
May 31, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	1 000 Value: $2K
May 29, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	3 026 Value: $6K
May 29, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	3 026 Value: $6K
May 28, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	6 000 Value: $11.4K
May 28, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	6 000 Value: $11.4K
Apr 02, 2024 Buy	Stock Options -Right to Buy A-Award	Peery Kimberly R. Chief Financial Officer	C-Suite Officer	40 000 Value: $120.4K
Apr 02, 2024 Buy	Stock Options -Right to Buy A-Award	Peery Kimberly R. Chief Financial Officer	C-Suite Officer	40 000 Value: $120.4K
Jan 02, 2024 Buy	Common Stock A-Award	Fischel Nathan	Director	64 935 Value: $0
Jan 02, 2024 Buy	Common Stock A-Award	Messey Robert J Director	Director	64 935 Value: $0
Jan 02, 2024 Buy	Common Stock A-Award	Curet Myriam Director	Director	64 935 Value: $0
Jan 02, 2024 Buy	Common Stock A-Award	Benfer David Director	Director	64 935 Value: $0
Jan 02, 2024 Buy	Common Stock A-Award	Levin Ross B Director	Director	64 935 Value: $0
Jan 02, 2024 Buy	Common Stock A-Award	Menawat Arun Swarup Director	Director	64 935 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT STEREOTAXIS

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the...

Read Full Profile Here